Epstein-Barr Virus-Infected Natural Killer Cell Leukemia

References

• Loughran T. P., Jr., Kadin M. E., Starkebaum G., Abkowitz J. L., Clark E. A., Disteche C., Lum L. G., Slichter S. J. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Annals of Internal Medicine 1985; 102: 169–175
   PubMed Web of Science ®Google Scholar
• Oshimi K., Yamada O., Kaneko T., Nishinarita S., Lizuka Y., Urabe A., Inamori T., Asano S., Takahashi S., Hattori M. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993; 7: 782–788
   PubMed Web of Science ®Google Scholar
• Loughran T. P. Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1–14
   PubMed Web of Science ®Google Scholar
• Semenzato G., Zambello R., Starkebaum G., Oshimi K., Loughran T. P. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89: 256–260
   PubMed Web of Science ®Google Scholar
• Posnett D. N., Sinha R., Kabak S., Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to “benign monoclonal gammapathy”. Journal of Experimental Medicine 1994; 179: 609–618
   PubMed Web of Science ®Google Scholar
• Akashi K., Shibuya T., Taniguchi S., Hayashi S., Iwasaki H., Teshima T. Y.T., Gondo H., Okamura T., Harada M., Niho Y. Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes. British Journal of Haematology 1999; 107: 670–673
   PubMed Web of Science ®Google Scholar
• Brinkman K., Van Dongen J. J., Van Lorn K., Groeneveld K., Misere J. F., Van Der Heul C. Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vbeta antibodies. Leukemia 1998; 12: 150–154
   PubMed Web of Science ®Google Scholar
• Gentile T. C., Wener M. H., Starkebaum G., Loughran T. P. Humoral immune abnormalities in T-cell large granular lymphocyte leukemia. Leukemia and Lymphoma 1996; 23: 365–370
   PubMed Web of Science ®Google Scholar
• Loughran T. P., Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987; 66: 397–405
   PubMed Web of Science ®Google Scholar
• Nash R., McSweeney P., Zambello R., Semenzato G., Loughran T. P. Clonal studies of CD3- lympho-proliferative disease of granular lymphocytes. Blood 1993; 81: 2363–2368
   PubMed Web of Science ®Google Scholar
• Tefferi A., Li C. Y., Witzig T. E., Dhodapkar M. V., Okuno S. H., Phyliky R. L. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994; 84: 2721–2725
   PubMed Web of Science ®Google Scholar
• Kawa-Ha K., Ishihara S., Ninomiya T., Yumura-Yagi K., Hara J., Murayama R., Tawa A., Hirai K. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. Journal of Clinical Investigation 1989; 84: 51–55
   PubMed Web of Science ®Google Scholar
• Imamura N., Kusunoki Y., Kawa-Ha K., Yumura K., Hara J., Oda K., Abe K., Dohy H., Inada T., Kajihara H. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. British Journal of Haematology 1990; 75: 49–59
   PubMed Web of Science ®Google Scholar
• Mizuno S., Akashi K., Ohshima K., Iwasaki H., Miyamoto T., Uchida N., Shibuya T., Harada M., Kikuchi M., Niho Y. Interferon-γ prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. Blood 1999; 93: 3494–3504
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Morinaga S., Takagi K., Chen J., Mugishima H., Ishii T., Sako M., Arakawa H., Kato M. Haemophagocytic lymphohistiocytosis in association with granular lymphocyte proliferative disorders in early childhood: characteristic bone marrow morphology. British Journal of Haematology 1997; 96: 708–714
   PubMed Web of Science ®Google Scholar
• Kobayashi Y., Uehara S., Inamori K., Shirato R., Ozawa K., Sklar J., Asano S. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia. International Journal of Hematology 1996; 64: 135–142
   PubMed Web of Science ®Google Scholar
• Ohshima K., Kikuchi M., Mizuno S., Akashi K., Moriyama K., Yoneda S., Takeshita M., Shibata T. Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr virus- containing natural killer cell leukaemia/lymphoma and T-cell lymphoma; mimicking malignant histiocytosis. Hematological Oncology 1995; 13: 83–97
   PubMed Web of Science ®Google Scholar
• Hart D. N., Baker B. W., Inglis M. J., Nimmo J. C., Starling G. C., Deacon E., Rowe M., Beard M. E. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992; 79: 2116–2123
   PubMed Web of Science ®Google Scholar
• Tsuchiyama J., Yoshino T., Mori M., Kondoh E., Oka T., Akagi T., Hiraki A., Nakayama H., Shibuya A., Ma Y., Kawabata T., Okada S., Harada M. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. Blood 1998; 92: 1374–1383
   PubMed Web of Science ®Google Scholar
• Henter J. I., Elinder G., Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The PHL Study Group of the Histiocyte Society. Seminar in Oncology 1991; 18: 29–33
   PubMed Web of Science ®Google Scholar
• Abbot S. D., Rowe M., Cadwallader K., Ricksten A., Gordon J., Wang F., Rymo L., Rickinson A. B. Epstein-Barr virus nuclear antigen 2 induces expression of the virus- encoded latent membrane protein. Journal of Virology 1990; 64: 2126–2134
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Nunez G., Milliman C., Schreiber R. D., Korsmeyer S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang P., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Wilson J. B., Bell J. L., Levine A. J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. Embo Journal 1996; 15: 3117–3126
   PubMed Web of Science ®Google Scholar
• Akashi K., Kondo M., Von Preeden-Jeffry U., Murray R., Weissman I. L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997; 89: 1033–1041
   PubMed Web of Science ®Google Scholar
• Fairbairn L. J., Cowling G. J., Reipert B. M., Dexter T. M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993; 74: 823–832
   PubMed Web of Science ®Google Scholar
• Lagasse E., Weissman I. L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997; 89: 1021–1031
   PubMed Web of Science ®Google Scholar
• Disanto J. P., Rieux-Laucat F., Dautry-Varsat A., Fischer A., De Saint Basile G. (1978) Defective human interleukin 2 receptor gamma chain in an atypical x chromosome-linked severe combined immunodeficiency with peripheral T cells. Proceedings of National Academy of Sciencei USA 1994; 91:9466–9470. 1994
   Google Scholar
• Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147–157
   PubMed Web of Science ®Google Scholar
• Kondo M., Akashi K., Domen J., Sugamura K., Weissman I. L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 1997; 7: 155–162
   PubMed Web of Science ®Google Scholar
• Akashi K., Shibuya T., Harada M., Takamatsu Y., Uike N., Eto T., Niho Y. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. Journal of Clinical Investigation 1991; 88: 223–230
   PubMed Web of Science ®Google Scholar
• Ross M. E., Caligiuri M. A. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997; 89: 910–918
   PubMed Web of Science ®Google Scholar
• Carson W. E., Ross M. E., Baiocchi R. A., Marien M. J., Boiani N., Grabstein K., Caligiuri M. A. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. Journal of Clinical Investigation 1995; 96: 2578–2582
   PubMed Web of Science ®Google Scholar
• Yang X. F., Weber G. F., Cantor H. A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 1997; 7: 629–639
   PubMed Web of Science ®Google Scholar
• Mandelboim O., Kent S., Davis D. M., Wilson S. B., Okazaki T., Jackson R., Hafler D., Strominger J. L. (1978) Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells. Proceedings of National Academy of Sciencei USA 1998; 95:3798–3803. 1998
   Google Scholar
• Imashuku S., Hibi S., Fujiwara F., Ikushima S., Todo S. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. British Journal of Haematology 1994; 88: 656–658
   PubMed Web of Science ®Google Scholar
• Akashi K., Hayashi S., Gondo H., Mizuno S., Harada M., Tamura K., Yamasaki K., Shibuya T., Uike N., Okamura T., Harada M., Niho Y. Involvement of interferons and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. British Journal of Haematology 1994; 87: 243–250
   PubMed Web of Science ®Google Scholar
• Kikuta H., Sakiyama Y., Matsumoto S., Oh-Ishi T., Nakano T., Nagashima T., Oka T., Hironaka T., Hirai K. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood 1993; 82: 3259–3264
   PubMed Web of Science ®Google Scholar
• Kawaguchi H., Miyashita T., Herbst H., Niedobitek G., Asada M., Tsuchida M., Hanada R., Kinoshita A., Sakurai M., Kobayashi N., Mizutani S. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus- associated hemophagocytic syndrome. Journal of Clinical Investigation 1993; 92: 1444–1450
   PubMed Web of Science ®Google Scholar
• Lay J. D., Tsao C. J., Chen J. Y., Kadin M. E., Su I. J. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. Journal of Clinical Investigation 1997; 100: 1969–1979
   PubMed Web of Science ®Google Scholar
• Yao M., Cheng A. L., Su I. J., Lin M. T., Uen W. C., Tien H. F., Wang C. H., Chen Y. C. Clinicopathological spectrum of haemophagocytic syndrome in Epstein- Barr virus-associated peripheral T-cell lymphoma. British Journal of Haematology 1994; 87: 535–543
   PubMed Web of Science ®Google Scholar
• Kanegane H., Wang F., Tosato G. Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma. Blood 1996; 88: 4667–4675
   PubMed Web of Science ®Google Scholar
• Kaneko T., Fukuda J., Yoshihara T., Zheng H., Mori S., Mizoguchi H., Oshimi K. Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. British Journal of Haematology 1995; 91: 355–361
   PubMed Web of Science ®Google Scholar
• Galy A., Travis M., Cen D., Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995; 3: 459–473
   PubMed Web of Science ®Google Scholar
• Kondo M., Weissman I. L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997; 91: 661–672
   PubMed Web of Science ®Google Scholar